Development
PROCEPT BioRobotics Corporation
PRCT
$62.91
-$2.14-3.29%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 2.37% | -8.88% | -31.81% | -65.75% | -53.54% |
| Total Depreciation and Amortization | 98.79% | 49.93% | -10.46% | 4.62% | -13.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.22% | 37.11% | 96.26% | 199.80% | 359.72% |
| Change in Net Operating Assets | 26.77% | 47.53% | -592.01% | -285.62% | -987.73% |
| Cash from Operations | 1.51% | 4.57% | -65.47% | -97.07% | -52.79% |
| Capital Expenditure | -906.35% | -281.77% | -2,364.22% | -9,607.27% | -160.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -906.35% | -281.77% | -2,364.22% | -9,607.27% | -160.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 92.74% | 20,764.74% | -15.09% | -70.57% | 130.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 317.45% | 20,764.74% | -15.09% | -70.57% | -304.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.00% | 767.36% | -116.00% | -140.58% | -69.25% |